Genetic diversity of Vif protein in human immunodeficiency virus type 1 variants (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus-1) that circulated in the Moscow region in 2019–2020
Problems of Virology · 2025
DOI: 10.36233/0507-4088-281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Problems of Virology, 2025. Verfasst von A A Antonova und 8 weiteren Autor:innen. Beteiligte Einrichtung: D.I. Ivanovsky Institute of Virology of National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya. Hauptthemen laut MEDLINE: HIV-1, vif Gene Products, Human Immunodeficiency Virus, HIV Infections, Genetic Variation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The Vif protein counteracts cellular deaminases, APOBEC3, which prevent viral replication. Vif is used for development of therapeutic agents. Natural polymorphisms in Vif can affect its functionality and may be associated with accelerated progression of HIV-infection to the AIDS. The study of Vif features in HIV-1 variants circulating in Russia has not been conducted previously. The aim of the study: to study the genetic diversity of Vif in the HIV-1 variants that circulated in the Moscow region in 2019–2020. Materials and methods. 234 whole blood samples obtained from HIV-infected patients without experience of therapy were analyzed. The study design included the following stages: extraction of proviral DNA, amplification of the vif gene, sequencing, identification of genetic variants, followed by a study of consensus sequences of the most common genetic variants of HIV-1, analysis of the conservation and genetic diversity of Vif-A6 (Vif protein of HIV-1 sub-subtype A6 variants) in patients with different stages of the disease, and assessment of genetic diversity of Vif-A6 in the Moscow region.
Results
A high degree of genetic diversity of vif gene was revealed. Consensus sequences of Vif in B and CRF63_02A6 variants were obtained for the first time. Characteristic substitutions in the consensus sequences were determined for the most common HIV-1 variants.
Conclusion
The limitation of this study is the small sample of B and CRF63_02A6. The results obtained may be of interest and may be taken into account in the development of therapeutic agents based on the Vif protein, as well as in the study of the pathogenicity of HIV-1 sub-subtype A6.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- D.I. Ivanovsky Institute of Virology of National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya.
- Center for the Prevention and Control of AIDS and Infectious Diseases.
ORCID-Profile: A A Antonova, L A Protasova, K V Kim, I M Munchak, E N Mezhenskaya, E A Orlova-Morozova, A Y Pronin, A G Prilipov, A I Kuznetsova
Zitieren
APA
Antonova, A. A., Protasova, L. A., Kim, K. V., Munchak, I. M., Mezhenskaya, E. N., Orlova-Morozova, E. A., Pronin, A. Y., Prilipov, A. G., & Kuznetsova, A. I. (2025). Genetic diversity of Vif protein in human immunodeficiency virus type 1 variants (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus-1) that circulated in the Moscow region in 2019–2020. Problems of Virology. https://doi.org/10.36233/0507-4088-281
Vancouver
Antonova AA, Protasova LA, Kim KV, Munchak IM, Mezhenskaya EN, Orlova-Morozova EA, et al. Genetic diversity of Vif protein in human immunodeficiency virus type 1 variants (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus-1) that circulated in the Moscow region in 2019–2020. Problems of Virology. 2025. doi:10.36233/0507-4088-281
BibTeX
@article{Antonova2025,
author = {Antonova, A A and Protasova, L A and Kim, K V and Munchak, I M and Mezhenskaya, E N and Orlova-Morozova, E A and Pronin, A Y and Prilipov, A G and Kuznetsova, A I},
title = {Genetic diversity of Vif protein in human immunodeficiency virus type 1 variants (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus-1) that circulated in the Moscow region in 2019–2020},
journal = {Problems of Virology},
year = {2025},
doi = {10.36233/0507-4088-281}
}
EUVIMED